TrialJournal of acquired immune deficiency syndromes (1999)2020

Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials.

Pedro Cahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.